Early Diagnosis of Esophageal Adenocarcinoma

Seminars in Gastrointestinal Disease

Volumn 14, Issue 3, 2003, Pages 136-145

  Buecher, Bruno ^a   Galmiche, Jean Paul ^a,b  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; DEVELOPED COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; GASTROESOPHAGEAL REFLUX; HUMAN; METAPLASIA; OPTICAL COHERENCE TOMOGRAPHY; PROGNOSIS; REVIEW; RISK FACTOR;

EID: 0242582136     PISSN: 10495118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Bollschweiler E, Wolfgarten E, Gutschow C, et al: Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92:549-555, 2001
2. Devesa SS, Blot WJ, Fraumeni JF: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053, 1998
3. Lagergren J, Bergstrom R, Lindgren A, et al: Symptomatic gastroesophageal reflux as a risk factor of esophageal adenocarcinoma. N Engl J Med 340:825-831, 1999
4. Cameron AJ, Zinsmeister AR, Ballard DJ, et al: Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 99:918-922, 1990
5. El-Serag HB: Segment length and risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 133:747-748, 2000
6. Eisen GM, Sandler RS, Murray S, et al: The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol 92:27-31, 1997
7. Lieberman D, Oehlke M, Helfand M: for the GORE Consortium: Risk factors for Barrett's esophagus in community-based practice. Am J Gastroenterol 92:1293-1297, 1997
8. Reynolds JC, Waronker M, Pacquing MS, et al: Barrett's esophagus. Reducing the risk of progression to adenocarcinoma. Gastroenterol Clin North Am 28:917-945, 1999
9. Levine DS, Haggit RC, Irvine S, et al: Natural history of high grade dysplasia in Barrett's esophagus. Gastrenterology 110:A550, 1996 (abstr)
10. Schnell TG, Sontag SJ, Chejfec G, et al: Long-term non-surgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 120:1607-1619, 2001
11. Muller JM, Erasmi H, Stelzner M, et al: Surgical therapy of esophageal carcinoma. Br J Surg 77:845-857, 1990
12. Christien JD, Hollinger EF, Millikan KW, et al: Prognostic factors associated with resectable carcinoma of the esophagus. Ann Surg 68:258-262, 2002
13. Tajima Y, Nakanishi Y, Ochiai A, et al: Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma. Analysis of 240 surgically resected tumors. Cancer 88:1285-1293, 2000
14. Nabeya K, Hanaoka T, Li S, et al: What is the ideal treatment for early esophageal cancer? Endoscopy 25: 670-671, 1993
15. Ide H, Nogami A, Hanashi T: A clinical study on prognosis of submucosal esophageal cancer. Stomach Intestine 25:1067-1074, 1990
16. Iwasaki Y, Takizawa T, Monma K: Pathological basis of enoscopic mucosectomy of superficial carcinoma. Stomach Intestine 28:125-132, 1993
17. Kato H, Tachimori Y, Watanabe H, et al: Superficial esophageal carcinoma: surgical treatment and the results. Cancer 66:2319-2323, 1990
18. Fujita H, Sueyoshi S, Yamana H, et al: Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg 25:424-431, 2001
19. Ell C, May A, Gossner L, et al: Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118:670-677, 2000
20. Barrioz T, Kaffy F, Gougeon JM, et al: Endoscopic mucosal resection of early adenocarcinoma and high-grade dysplasia in Barrett's esophagus: Results in 24 patients. Endoscopy 33:A21, 2001 (abstr)
21. Nijhawan PK, Wang KK: EMR for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within BE. Gastrointest Endosc 52:328-332, 2000
22. Gossner L, Stolte M, Sroka R, et al: Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic. Gastroenterology 114:448-455, 1998
23. Soelikno RM, Inoue H, Chang KJ: Endoscopic mucosal resection. Gastrointest Endosc Clin North Am 10:595-617, 2000
24. Yoshida M, Hanashi T, Momma K, et al: Endoscopic mucosal resection for radical treatment of esophageal cancer. Gan To Kagaku Ryoho 22:847-854, 1995
25. Wolfsen HC, Woodward TA, Raimondo M: Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 77:1176-1181, 2002
26. Shami VM, Waxman I: Endoscopic treatment of early gastroesophageal malignancy. Curr Opin Gastroenterol 18:587-594, 2002
27. Freston JW, Malagelada JR, Petersen H, et al: Critical issues in the management of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 7:577-586, 1995
28. Reid R, Blount P, Feng Z, et al: Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 95:3089-3096, 2000
29. Reid BJ, Weinstein WM, Lewin KJ, et al: Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 94:81-90, 1988
30. Ferguson MK, Durkin A: Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and non-surveyed patients. J Gastrointest Surg 6:29-35, 2002
31. Incarbone R, Bonavina L, Saino G, et al: Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surg Endosc 16:263-266, 2002
32. Van Sandick JW, van Lanschot JJB, Kuiken BW, et al: Impact of endoscopic biopsy surveillance of Barrett's esophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43:216-22, 1998
33. Barr H: Protagonist: endoscopic surveillance of patients with Barrett's oesophagus. Gut 51:313-314, 2002
34. Playford RJH: Antagonist: Endoscopic surveillance of patients with Barrett's oesophagus. Gut 51:314-315, 2002
35. Canto MI, Setrakian S, Willis JE, et al: Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 51:560-568, 2000
36. Kiesslich R, Hahn M, Herrmann G, et al: Screening for specialized columnar epithelium with methylene blue: Chromoendoscopy in patients with Barrett's esophagus and a normal control group. Gastrointest Endosc 53:47-52, 2001
37. Canto MI, Setrakian S, Willis JE, et al: Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: An in vivo and ex vivo study. Endoscopy 33:391-400, 2001
38. Egger K, Werner M, Meining A, et al: Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut 52:18-23, 2003
39. Tabuchi M, Sueoka N, Fujimori T: Videoendoscopy with vital double dye staining (crystal violet and methylene blue) for detection of a minute focus of early stage adenocarcinoma in Barrett's esophagus: A case report. Gastrointest Endosc 54:385-388, 2001
40. Kato S, Fujii T, Koba I, et al: Assessment of colorectal lesions using magnifying colonoscopy and mucosal dye spraying: Can significant lesions be distinguished? Endoscopy 33:306-310, 2001
41. Stevens PD, Lightdale CJ, Green PHR, et al: Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. Gastrointest Endosc 40:747-749, 1994
42. Endo T, Awakawa T, Takahashi H, et al: Classification of Barrett's epithelium by magnifying endoscopy. Gastrointest Endosc 55:641-647, 2002
43. Guelrud M, Herrera I, Essenfeld H, et al: Enhanced magnification endoscopy: A new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 53:559-565, 2001
44. Sharma P, Weston AP, Topalovski M, et al: Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gut 52:24-27, 2003
45. Yao K, Oishi T, Matsui T, et al: Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer. Gastrointest Endosc 56:279-284, 2002
46. Shibuya K, Hoshino H, Chiyo M, et al: Subepithelial vascular patterns in bronchial dysplasias using a high magnification bronchovideoscope. Thorax 57:902-907, 2002
47. Kumagai Y, Inoue H, Nagai K, et al: Magnifying endoscopy, stereoscopic microscopy, and the microvascular architecture of surperficial esophageal carcinoma. Endoscopy 34:369-375, 2002
48. Nakayoshi Y, Incue H, Nagai K, et al: Preliminary experiences of magnifying endoscopy with narrow band imaging system for early gastric cancer. Gastroint Endosc 55:A106, 2002 (abstr)
49. Panjehpour M, Overholt BF, Schmidhammer JL, et al: Spectroscopic diagnosis of esophageal cancer: New classification model, improved measurement system. Gastrointest Endosc 41:577-581, 1995
50. Mayinger B, Horner P, Jordan M, et al: Light-induced autofluorescence spectroscopy for the endoscopic detection of esophageal cancer. Gastrointest Endosc 54:195-201, 2001
51. Mayinger B, Horner P, Jordan M, et al: Endoscopic fluorescence spectroscopy in the upper GI tract for the detection of GI cancer: Initial experience. Am J Gastroenterol 96:2616-2621, 2001
52. Panjehpour M, Overholt BF, Vo-Dinh T, et al: Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus. Gastroenterology 111:93-101, 1996
53. Brand S, Wang TD, Schomacker KT, et al: Detection of high-grade dysplasia in Barret's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Gastrointest Endosc 56:479-487, 2002
54. Georgakoudi I, Jacobson B, Van Dam J, et al: Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology 120:1620-1629, 2001
55. Wallace M, Perelman L, Backman V, et al: Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy. Gastroenterology 119:677-682, 2000
56. Haringsma J, Tytgat GN, Yano H, et al: Autofluorescence endoscopy: Feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc 53:642-650, 2001
57. Endlicher E, Knuechel R, Hauser T, et al: Endoscopic fluorescence detection oflow- and high-grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation. Gut 48:314-319, 2001
58. Gossner L, Sroka R, Stepp H, et al: Photodynamic diagnosis versus random biopsies for dysplasia and invisible mucosa cancer in Barrett's esophagus-A prospective randomized trial. Gastroenterology 116:A175, 1999 (abstr)
59. Zuccaro G, Gladkova N, Vargo J, et al: Optical coherence tomography of the esophagus and proximal stomach in health and disease. Am J Gastroenterol 96:2633-2639, 2001
60. Jackle, S, Gladkova N, Feldchtein F, et al: In vivo endoscopic optical coherence tomography of esophagitis, Barrett's esophagus and adenocarcinoma of the esophagus. Endoscopy 32:750-755, 2000
61. Poneros JM, Brand S, Bouma BE, et al: Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology 120:7-12, 2001
62. Li XD, Boppart SA, Van Dam J, et al: Optical coherence tomography: Advanced technology for the endoscopic imaging of Barrett's esophagus. Endoscopy 32:921-930, 2000
63. Koenig F, Knittel J, Stepp H: Diagnosing cancer in vivo. Science 292:1401-1403, 2001